Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 78 Neoplasm Metastasis 16 Neoplasms 9 Breast Neoplasms, Male 9 Brain Neoplasms 6 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Prostatic Neoplasms 3 Lung Neoplasms 3 Carcinoma, Squamous Cell 3 Carcinoma, Ovarian Epithelial 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Pancreatic Neoplasms 2 Neuroma, Acoustic 2 Neurofibromatosis 2 2 Inflammatory Breast Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Ductal, Breast 2 Salivary Gland Neoplasms 1 Recurrence 1 Prolactinoma 1 Pituitary Neoplasms 1 Patient Compliance 1 Neuroectodermal Tumors, Primitive 1

Interventions

Surveys and Questionnaires 2 Radiotherapy 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Lapatinib 1 Irinotecan 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Exercise 1 Diet Therapy 1 Carboplatin 1 Capecitabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × GastroEsophageal Cancer × Lapatinib × Clear all

NCT01145404 2014-07-02

GastroLap

National Center for Tumor Diseases, Heidelberg

Phase 2 Terminated

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡